Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

102.71
Delayed Data
As of Jul 02
 -1.15 / -1.11%
Today’s Change
37.77
Today|||52-Week Range
105.97
+134.07%
Year-to-Date
No recent news for Ultragenyx Pharmaceutical Inc.

Today’s Trading

Previous close103.86
Today’s open104.02
Day’s range100.16 - 104.77
Volume231,468
Average volume (3 months)439,906
Market cap$3.7B
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+84.87%
Earnings growth (this year)-14.11%
Earnings growth (next 5 years)+75.40%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book17.74

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...-0.15-0.13%
ANACAnacor Pharmaceutica...-1.20-1.50%
GRFSGrifols SA-0.24-0.77%
NBIXNeurocrine Bioscienc...-0.35-0.73%
Data as of 4:01pm ET, 07/02/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$0.00
Annual profit (last year)-$59.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Emil D. Kakkis
CFO, Senior VP &
Head-Investor Relations
Shalini Sharp
Corporate headquarters
Novato, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers